July 28, 2014 - ZOLL Medical awarded 3 year contract to supply X Series Defibrillators to West Midlands Ambulance Service NHS Foundation Trust

 

MEDIA CONTACT:  

Jill Garratt
ZOLL Medical U.K. Ltd
01928 595 160
jgarratt@zoll.com

 

ZOLL Medical Awarded 3 Year Contract to Supply X Series Monitor/Defibrillators to West Midlands Ambulance Service NHS Foundation Trust 

WMAS ambulance pic

July 28, 2014—Cheshire, UK.— The prestigious award for the supply of pre-hospital defibrillators to the West Midlands Service NHS Foundation Trust has been awarded to ZOLL® Medical UK Ltd.  The decision was made after a thorough evaluation of the ZOLL X Series® monitor/defibrillator by the clinical team at West Midlands Ambulance. The award will see the ambulance service replace all of its existing monitors with the latest technology from ZOLL.

Weighing less than 6 kilograms, the X Series is half the size and half the weight of most full-featured defibrillators, yet powerful and built to the most rigorous standards for ruggedness. The X Series has every advanced monitoring and communication capability required by a leading ambulance service.

Andrew Carson, Medical Director, West Midlands Service NHS Foundation Trust said “The X Series monitor/defibrillator allows clinicians to provide improved clinical care and treatment at the patient side. These defibrillators offer the very best in clinical diagnostic tools and provide our patients optimal care in the community, before making the decision to convey them to hospital.  The high specification devices will enhance the clinical treatment through EtCO2 monitoring, high-quality 12-lead ECG acquisition, and robust telemetry.”  

Richard Knell-Moore, ZOLL UK Country Manager, said “We are delighted to be to continuing our partnership with the West Midlands Ambulance Service NHS Foundation Trust. The trust is one of the highest profile services in the UK and we are proud to say that they will continue to use the very latest ZOLL technologies.  The Trust serves a population of 5.36 million people covering an area of more than 5,000 square miles and provides some unique challenges. The fact that the Trust chose the X Series to meet their clinical requirements and the operational demands that they face every day, is a testament to the design and functionality of the device.”  

For more information on X Series please visit www.zoll.com or call 01928 595 160.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 29,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

Copyright © 2014 ZOLL Medical Corporation. All rights reserved. AutoPulse and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All product names are the property of their respective owners.